Marksans Pharma Limited — Credit Ratings, 28-10-2024: Credit Rating

Marksans Pharma Limited announced that CARE Ratings has reaffirmed their long-term bank facilities rating at CARE A+ and revised the outlook to positive. The long-term facilities amount has been reduced to ₹135 crore. Additionally, short-term bank facilities of ₹25 crore and ₹95.75 crore have been assigned and reaffirmed a rating of CARE A1+, respectively. For more details, visit their corporate announcements page.